Generally, elderly patients diagnosed with type 2 diabetes or obesity can safely take semaglutide to improve glycemic control and curb the risk of cardiovascular events
Most patients report noticeable improvements within 2-3 weeks of starting therapy
Therefore, understanding the cause is necessary for the proper treatment
So I think seeing the progression of that and looking at outcome studies will be key before we make a decision of whether or not we want to include that in our care. Road to Reimbursement Because GLP-1s are a new drug within health care in general and there are not yet any clinical standards for its use across substance use disorder care, serious mental illnesses or eating disorders, the road to eventual reimbursement for including it in care is one all practitioners told BHB they will be closely monitoring
Fella versus Ro Ro charges a monthly platform fee (around $145) on top of medication costs, which can make the total more expensive than Fella despite appearing cheaper initially
Ital J Pediatr 44 (Suppl 2), 131 (2018)